Sanofi (SNY) Change in Account Payables (2013 - 2021)

Sanofi has disclosed Change in Account Payables across 4 years of filings, most recently posting $101.7 million for Q4 2021.

• Change in Account Payables for Q4 2021 came in at $101.7 million, up 616.78% year-over-year; the trailing twelve-month figure through Dec 2021 was $275.3 million (changed N/A YoY), and the FY2025 annual result was $463.3 million, down 45.05% from the prior year.
• Change in Account Payables came in at $101.7 million for Q4 2021 at Sanofi, up from $14.2 million in the prior quarter.
• In the past five years, Change in Account Payables ranged from a high of $101.7 million in Q4 2021 to a low of -$1.2 million in Q4 2019.
• The 3-year median for Change in Account Payables is $14.2 million (2020), against an average of $38.2 million.
• Across the five-year window, Change in Account Payables surged 1265.29% in 2020 and surged 616.78% in 2021, its largest moves.
• Sanofi's Change in Account Payables stood at -$1.2 million in 2019, then soared by 1265.29% to $14.2 million in 2020, then soared by 616.78% to $101.7 million in 2021.
• The last three Change in Account Payables figures came in at $101.7 million (Q4 2021), $14.2 million (Q4 2020), and -$1.2 million (Q4 2019), per Business Quant data.